BusinessInnovest Global, Inc. Reports Q1 Revenue Beating Estimates, Quick Ratio Four Times Conglomerate Industry Average - Spotlight GrowthBy Nasdaq OMXApr 20, 2018, 12:00 PM UTC
BusinessVBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B VaccineBy Nasdaq OMXApr 19, 2018, 12:00 PM UTC
BusinessApellis Pharmaceuticals Announces Pricing of Offering of Common StockBy Nasdaq OMXApr 19, 2018, 1:26 AM UTC
BusinessInnovest Global Inc. $932K in Current Assets and Cancelled 50 Million Shares, Q1 HighlightsBy Nasdaq OMXApr 17, 2018, 12:01 PM UTC
BusinessVBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) PatientsBy Nasdaq OMXApr 17, 2018, 12:01 PM UTC
BusinessEmerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy StoresBy Nasdaq OMXApr 17, 2018, 11:01 AM UTC
BusinessApellis Pharmaceuticals Announces Proposed Offering of Common StockBy Nasdaq OMXApr 16, 2018, 9:12 PM UTC
BusinessInnovest Global Inc. Q1 Financials Beat Revenue Estimates, $600K+ Cash on Hand, and Cancelled 50 Million of its Outstanding SharesBy Nasdaq OMXApr 16, 2018, 7:02 PM UTC
